Steve Mandel acquired 11.8M Medline shares worth $425M. That's 2.63% of their equity portfolio (16th largest holding). The investor owns 1.49% of the outstanding Medline stock. The investor's estimated purchase price is $505M, resulting in a loss of 16%.